• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性每日吸食大麻者血液中大麻素延长排泄对自身吸毒驾车法律的影响。

Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws.

机构信息

Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.

出版信息

Clin Chem. 2013 Mar;59(3):519-26. doi: 10.1373/clinchem.2012.195503.

DOI:10.1373/clinchem.2012.195503
PMID:23449702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3717350/
Abstract

BACKGROUND

Cannabis is the illicit drug most frequently reported with impaired driving and motor vehicle accidents. Some "per se" laws make it illegal to drive with any amount of drug in the body, while others establish blood, saliva, or urine concentrations above which it is illegal to drive. The persistence of Δ(9)-tetrahydrocannabinol (THC) in chronic daily cannabis smokers' blood is unknown.

METHODS

Thirty male chronic daily cannabis smokers resided on a secure research unit for up to 33 days, with daily blood collection. Samples were processed in an ice bath during sample preparation to minimize cannabinoid adsorption onto precipitant material. We quantified THC by 2-dimensional GC-MS.

RESULTS

Of the 30 participants, 27 were THC-positive on admission, with a median (range) concentration of 1.4 μg/L (0.3-6.3). THC decreased gradually; only 1 of 11 participants was negative at 26 days, 2 of 5 remained THC-positive (0.3 μg/L) for 30 days, and 5.0% of participants had THC ≥ 1.0 μg/L for 12 days. Median 11-hydroxy-THC concentrations were 1.1 μg/L on admission, with no results ≥ 1.0 μg/L 24 h later. 11-Nor-9-carboxy-THC (THCCOOH) detection rates were 96.7% on admission, decreasing slowly to 95.7% and 85.7% on days 8 and 22, respectively; 4 of 5 participants remained THCCOOH positive (0.6-2.7 μg/L) after 30 days, and 1 remained positive on discharge at 33 days.

CONCLUSIONS

Cannabinoids can be detected in blood of chronic daily cannabis smokers during a month of sustained abstinence. This is consistent with the time course of persisting neurocognitive impairment reported in recent studies.

摘要

背景

大麻是与驾驶障碍和机动车事故相关的最常见的非法药物。一些“绝对”法律规定,体内有任何毒品就不能驾驶,而另一些法律则规定血液、唾液或尿液中的毒品浓度超过一定水平就不能驾驶。慢性每日吸食大麻者血液中 Δ(9)-四氢大麻酚(THC)的持续存在情况尚不清楚。

方法

30 名男性慢性每日吸食大麻者在一个安全的研究单位居住,时间长达 33 天,每天采集血液样本。在样本制备过程中,将样本置于冰浴中以尽量减少大麻素吸附到沉淀材料上。我们通过二维 GC-MS 定量检测 THC。

结果

30 名参与者中,有 27 名在入院时 THC 检测呈阳性,中位数(范围)浓度为 1.4 μg/L(0.3-6.3)。THC 逐渐下降;在 26 天时,只有 11 名参与者中 1 名呈阴性,5 名中有 2 名仍呈 THC 阳性(0.3μg/L),30 天时 5.0%的参与者有 12 天 THC≥1.0μg/L。入院时 11-羟基-THC 的中位数浓度为 1.1μg/L,24 小时后没有结果≥1.0μg/L。入院时 THCCOOH 的检测率为 96.7%,分别缓慢下降至第 8 天的 95.7%和第 22 天的 85.7%;5 名参与者中有 4 名在 30 天后仍呈 THCCOOH 阳性(0.6-2.7μg/L),1 名在 33 天出院时仍呈阳性。

结论

在持续戒断一个月期间,可以在慢性每日吸食大麻者的血液中检测到大麻素。这与最近研究中报道的持续神经认知障碍的时间过程一致。

相似文献

1
Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws.慢性每日吸食大麻者血液中大麻素延长排泄对自身吸毒驾车法律的影响。
Clin Chem. 2013 Mar;59(3):519-26. doi: 10.1373/clinchem.2012.195503.
2
Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.长期频繁吸食大麻者在持续戒断期间血浆大麻素排泄延长及其与精神运动表现的相关性
Drug Test Anal. 2016 Jul;8(7):682-9. doi: 10.1002/dta.1825. Epub 2015 Jun 11.
3
Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.慢性、每日吸食大麻的人群在持续、监测下的戒断期间的唾液液大麻素。
Clin Chem. 2011 Aug;57(8):1127-36. doi: 10.1373/clinchem.2011.164822. Epub 2011 Jun 15.
4
Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.近期大麻使用的鉴定:受控吸食大麻后全血和血浆游离型及结合型大麻素药代动力学。
Clin Chem. 2011 Oct;57(10):1406-14. doi: 10.1373/clinchem.2011.171777. Epub 2011 Aug 11.
5
Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.大麻素依赖患者接受屈大麻酚药物治疗期间的血浆大麻素浓度。
Ther Drug Monit. 2014 Apr;36(2):218-24. doi: 10.1097/FTD.0b013e3182a5c446.
6
Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?偶尔吸烟者和频繁吸烟者尿液中大麻素的分布:频繁吸烟者尿样中 THC-葡糖苷酸是否是近期使用的标志物?
Clin Chem. 2014 Feb;60(2):361-72. doi: 10.1373/clinchem.2013.214106. Epub 2013 Nov 1.
7
Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.I 期和 II 期吸食大麻后偶尔和经常吸烟者的血液和血浆中大麻素的处置
Clin Chem. 2014 Apr;60(4):631-43. doi: 10.1373/clinchem.2013.216507. Epub 2014 Feb 21.
8
Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.口服Δ(9)-四氢大麻酚 24 小时给药后口腔液和血浆中的大麻素比值。
Clin Chem. 2011 Nov;57(11):1597-606. doi: 10.1373/clinchem.2011.169490. Epub 2011 Aug 29.
9
Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.慢性大麻吸食者的血浆 Delta9-四氢大麻酚、11-羟基-THC 和 11-去甲-9-羧基-THC 浓度的意义。
J Anal Toxicol. 2009 Oct;33(8):469-77. doi: 10.1093/jat/33.8.469.
10
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.慢性频繁吸烟者和偶尔吸烟者吸食管制大麻后口腔液中的大麻素浓度。
Anal Bioanal Chem. 2013 Oct;405(26):8451-61. doi: 10.1007/s00216-013-7291-5. Epub 2013 Aug 17.

引用本文的文献

1
Review of cannabis use and propofol anesthesia: recent insights and clinical implications.大麻使用与丙泊酚麻醉的综述:最新见解与临床意义
Curr Opin Anaesthesiol. 2025 Jul 1. doi: 10.1097/ACO.0000000000001548.
2
Bridging THC Knowledge Gaps for Safer Roads: A Call for Action.弥合四氢大麻酚知识差距,打造更安全道路:行动呼吁。
Clin Pharmacol Ther. 2025 Sep;118(3):548-550. doi: 10.1002/cpt.3717. Epub 2025 May 15.
3
Improvements in health-related quality of life are maintained long-term in patients prescribed medicinal cannabis in Australia: The QUEST Initiative 12-month follow-up observational study.

本文引用的文献

1
Antagonist-elicited cannabis withdrawal in humans.拮抗剂诱发的人类大麻戒断症状。
J Clin Psychopharmacol. 2011 Oct;31(5):603-12. doi: 10.1097/JCP.0b013e31822befc1.
2
Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.近期大麻使用的鉴定:受控吸食大麻后全血和血浆游离型及结合型大麻素药代动力学。
Clin Chem. 2011 Oct;57(10):1406-14. doi: 10.1373/clinchem.2011.171777. Epub 2011 Aug 11.
3
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.
澳大利亚开具药用大麻处方患者的健康相关生活质量改善情况长期维持:QUEST计划12个月随访观察性研究
PLoS One. 2025 Apr 2;20(4):e0320756. doi: 10.1371/journal.pone.0320756. eCollection 2025.
4
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques.大麻使用戒断与精神障碍风险:来自首发病例对照欧盟基因与环境交互作用项目2研究的病例对照分析:大麻使用戒断与精神障碍风险:一项来自以首发精神病发作病例对照为中心的欧盟基因与环境交互作用项目2研究的病例对照分析
Can J Psychiatry. 2025 Mar;70(3):182-193. doi: 10.1177/07067437241290187. Epub 2025 Jan 15.
5
Cannabis Use and Biomarkers of Inflammation, Immune Activation, and Microbial Translocation in Persons with HIV.艾滋病毒感染者使用大麻与炎症、免疫激活及微生物易位生物标志物的关系
Cannabis Cannabinoid Res. 2024 Dec;9(6):e1579-e1587. doi: 10.1089/can.2023.0109. Epub 2024 Feb 9.
6
Assessing Cannabis Use in People with Psychosis.评估精神病患者的大麻使用情况。
Cannabis Cannabinoid Res. 2024 Feb;9(1):49-58. doi: 10.1089/can.2023.0032. Epub 2023 Nov 16.
7
Circulating Endocannabinoids and N-Acylethanolamines in Individuals with Cannabis Use Disorder-Preliminary Findings.大麻使用障碍患者体内循环内源性大麻素和N-酰基乙醇胺——初步研究结果
Brain Sci. 2023 Sep 27;13(10):1375. doi: 10.3390/brainsci13101375.
8
Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis Syndrome.急诊科疑似大麻呕吐综合征患者的大麻使用模式和全血大麻素特征。
Ann Emerg Med. 2023 Aug;82(2):121-130. doi: 10.1016/j.annemergmed.2023.03.005. Epub 2023 Apr 13.
9
The Effects of β-myrcene on Simulated Driving and Divided Attention: A Double-Blind, Placebo-Controlled, Crossover Pilot Study.β-月桂烯对模拟驾驶和分散注意力的影响:一项双盲、安慰剂对照、交叉试验性研究。
Cannabis. 2023 Feb 7;6(1):9-19. doi: 10.26828/cannabis/2023.01.002. eCollection 2023.
10
Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests.大麻影响下的驾驶行为:毒理学检测与现场清醒测试相结合的影响。
Clin Chem. 2023 Jul 5;69(7):724-733. doi: 10.1093/clinchem/hvad054.
慢性每日吸食大麻者大脑中大麻素 CB1 受体的可逆和区域性选择性下调。
Mol Psychiatry. 2012 Jun;17(6):642-9. doi: 10.1038/mp.2011.82. Epub 2011 Jul 12.
4
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users.重度大麻使用者对 THC 和酒精的神经认知效应的耐受性和交叉耐受性。
Psychopharmacology (Berl). 2011 Mar;214(2):391-401. doi: 10.1007/s00213-010-2042-1. Epub 2010 Oct 30.
5
How important are sex differences in cannabinoid action?大麻素作用中的性别差异有多大重要性?
Br J Pharmacol. 2010 Jun;160(3):544-8. doi: 10.1111/j.1476-5381.2010.00776.x.
6
Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?大麻素 Delta9-四氢大麻酚浓度能否反映慢性大麻使用者近期的使用情况?
Addiction. 2009 Dec;104(12):2041-8. doi: 10.1111/j.1360-0443.2009.02705.x. Epub 2009 Oct 5.
7
Pharmacotherapy for cannabis dependence: how close are we?大麻依赖的药物治疗:我们进展如何?
CNS Drugs. 2009;23(7):543-53. doi: 10.2165/00023210-200923070-00001.
8
Marijuana neurobiology and treatment.大麻神经生物学与治疗
Subst Abus. 2008;29(3):17-29. doi: 10.1080/08897070802218166.
9
Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.重度和偶尔使用大麻者在急性四氢大麻酚中毒期间的神经认知表现。
J Psychopharmacol. 2009 May;23(3):266-77. doi: 10.1177/0269881108092393. Epub 2008 Aug 21.
10
Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.大麻影响下驾驶:一项关于血液中四氢大麻酚浓度的年龄和性别差异的十年研究。
Addiction. 2008 Mar;103(3):452-61. doi: 10.1111/j.1360-0443.2007.02091.x. Epub 2008 Jan 8.